Age-adjusted fGM | fWM | Age-adjusted fCSF | |||||
---|---|---|---|---|---|---|---|
Clinical marker | n | Sr | P | Sr | P | Sr | P |
Duration of disease (y) | 47 | NS | −0.54 | <0.0001 | 0.47 | 0.0013 | |
Stage (total functional capacity score) | 47 | 0.31 | 0.035 | 0.46 | 0.0014 | −0.52 | <0.0001 |
Loss of total functional capacity units per year | 36* | −0.33 | 0.048 | NS | 0.37 | <0.026 |
↵* Patients beyond 5 y from onset of HD.
Sr = Spearman rank correlation; NS = not significant.